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within the last 6 months, had a smoking history Ն 10 pack-years, had any major respiratory disease other than asthma, had a respiratory tract infection, or used oral prednisone in the previous 4 weeks. Written informed consent was obtained from all subjects, and the study was approved by the Human Research Ethics Committee of the South-Western Sydney Area Health Service (protocol number X06-0046).
Study Design
This was a cross-sectional study in which all data were collected in a single visit. Short-and long-acting b 2 -agonists were withheld for 6 h and 24 h before testing, respectively. Subjects completed a questionnaire about medication use, disease duration, and smoking history, and the Asthma Control Questionnaire (ACQ). 15 Subjects with ACQ scores , 0.75 were classifi ed as well controlled, between 0.75 and 1.5 as intermediately controlled, and scores Ն 1.5 were classifi ed as poorly controlled. 16 Atopic status was determined by skin prick test to common aeroallergens.
Exhaled Nitric Oxide
F eno was measured as an indirect marker of airway infl ammation. It was measured using an off-line technique according to American Thoracic Society guidelines. 17 Subjects inhaled room air through a nitric oxide scrubber and exhaled against a small resistance into an nitric oxide-impermeable polyethylene bag (Scholle Industries Pty Ltd; Elizabeth West, South Australia, Australia) at a constant fl ow of 0.2 L/s. The exhaled gas was analyzed using a chemiluminescence analyzer (model 42C; Thermo Environmental Instruments Inc; Franklin, Massachusetts). The upper limit of normal F eno 0.2 in adults is 13 parts per billion (ppb). 18 
Spirometry and Plethysmography
Spirometry and plethysmography were performed using a Sensormedics Vmax spirometer (Sensormedics Corp; Yorba Linda, California) and a Medisoft BodyBox 5500 (Medisoft Corp; Sorrines, Belgium). Results were reported as percent predicted. 3, 19 Ventilation Heterogeneity Ventilation heterogeneity was measured by the multiple-breath nitrogen washout as previously described. 9 Briefl y, a closed-circuit, bag-in-box breathing system was used to deliver 100% oxygen, which subjects breathed at a tidal volume of 1.0 to 1.3 L, until end-tidal nitrogen concentration dropped to 1/40 of the starting alveolar nitrogen concentration. The indices of ventilation heterogeneity in the regions of the lung where gas transport occurs predominantly by convection (Scond) and by diffusion (Sacin) were derived as previously described. 20 
Methacholine Challenge
Methacholine challenge tests were performed using hand-held De Vilbiss No 45 nebulizers (Sunrise Medical; Carlsbad, California), with doses ranging from 0.05 m mol to 6.1 m mol using the rapid method. 21 Response to challenge was measured by the doseresponse slope (DRS), which is calculated as ([% fall in FEV 1 / m mol methacholine] 1 3). 22 AHR was defi ned as DRS . 8% fall in FEV 1 / m mol (equivalent to FEV 1 provocative dose causing a 20% reduction in FEV 1 , 4 m mol).
Statistical Analysis
Data were analyzed using the Analyze-It software for Microsoft Excel (Analyze-It Software Ltd; Leeds, England). DRS and fraction of nitric oxide in exhaled breath (F eno ), 8, 9 heterogeneous distribution of ventilation, 9 and airway closure. 10 Little is known about the effects of age on the clinical outcomes or pathophysiologic pre dictors of AHR. Age-related changes in the infl ammatory profi le in asthma suggest that the role of eosinophilic infl ammation as a driver of AHR may be less important as patients age. Neutrophilic infl ammation increases in older patients with asthma 11 and eosinophilic cell function changes as patients get older. 12 Ventilation heterogeneity also changes with age, increasing dramatically at around 50 years of age. 13 Lung function is reduced in older patients with asthma, which may be due to increased airway remod eling as a result of longer duration of disease and also to the loss of lung elastic recoil. Such impairments may also lead to greater lung hyperinfl ation and airway closure, the latter being associated with more severe AHR 10 and severe disease. 14 We hypothesized that AHR is determined by different pathophysiologic processes in old compared with young adults with asthma. We propose that as the infl ammatory profi le and airway mechanical properties alter with age, other pathophysiologic processes, such as increased ventilation heterogeneity and airway closure, assume greater importance in predicting AHR. The aim of this study was to determine the predictors of AHR in old patients with asthma and to compare these with the predictors in young patients with asthma.
Materials and Methods

Subjects
Subjects were recruited by advertising throughout The University of Sydney and from the volunteer database at the Woolcock Institute of Medical Research. Inclusion criteria were physician diagnosis of asthma plus current symptoms of asthma requiring regular treatment. Subjects were excluded if they had smoked less atopic, but this was not statistically signifi cant. More old patients with asthma were receiving regular inhaled corticosteroid (ICS) treatment than young patients with asthma; however, in those taking ICSs, dosages were comparable between the groups. The number of subjects in each asthma control (ACQ) classifi cation was similar in the old and young. Smoking history was negligible, as there were only seven ex-smokers in total (fi ve old and two young), with median (interquartile range) smoking history of 5 (2-8) pack-years.
Univariate Correlations With DRS
In both old and young patients with asthma, DRS correlated negatively with % predicted FEV 1 and % predicted FEV 1 /FVC and positively with % predicted RV ( Table 2 ). DRS correlated with F eno in the young but not in the old group. DRS positively correlated with Sacin in the old and with Scond in the young ( Fig 1 ) . DRS was a signifi cant predictor of asthma control, measured by ACQ in both old ( r 5 0.62, P , .0001) and young ( r 5 0.42, P , .001) patients with asthma. Table 3 shows the results of the multiple linear regression analyses. In the old group, the independent predictors of DRS were % predicted RV, Sacin, and % predicted FEV 1 (model r 2 5 0.57, P , .0001). In the young group, DRS was independently predicted F eno were log-normally distributed and were log 10 transformed for all analyses. Because ventilation heterogeneity increases sharply at 50 years of age, 13 subjects were classifi ed into two age groups: young ( , 50 years) and old ( Ն 50 years). Testing of interactions between age group and each of the independent variables showed signifi cant interactions between age group and F eno , and age group and Scond. Therefore, the univariate and multivariate associations between DRS and the predictor variables were analyzed separately for each age group. Separate backward, stepwise, multiple linear regressions were conducted to determine the predictors of logDRS in old and young patients with asthma and included the following factors: Scond, Sacin, F eno , % predicted FEV 1 , % predicted FVC, % predicted FEV 1 /FVC, % predicted residual volume (RV), and BMI. Data are presented as means with 95% CIs unless otherwise specifi ed. P values , .05 were considered statistically signifi cant.
Multivariate Correlations With DRS
Results
Subjects
One hundred four subjects with asthma participated in the study. Table 1 shows the characteristics of subjects in the young and old groups. The prevalence of AHR was lower in the old group (49%) than in the young group (70%, P 5 .03). Compared with young patients with asthma, the old patients with asthma had longer disease duration, more airfl ow obstruction, less severe AHR, and lower F eno . Diffusiondependent ventilation heterogeneity (Sacin) was worse in the old group than in the young group, whereas convection-dependent ventilation heterogeneity (Scond) was similar. The old group tended to be 
Discussion
In this study of young (18-46 years) and old ( Ն 50 years) adults with asthma, we found differences in the pathophysiologic determinants of AHR. The presence of signifi cant interactions between age group and key predictor variables implied that there were signifi cant qualitative differences between age groups in their relationship with AHR, which made it essential to analyze the two groups separately. In old patients with asthma, AHR was predicted by gas trapping (% predicted RV), Sacin, and airway obstruction (% predicted FEV 1 ). In young patients with asthma, AHR was predicted by airway obstruction (% predicted FEV 1 /FVC), F eno , and Scond. The important health burden of asthma in the elderly was recognized in a recent review by Braman, 23 To determine if the differences between young and old groups were a refl ection of differences in ICS use, the data were reanalyzed after limiting the data set to subjects currently taking regular ICS therapy. In this subset, there were no signifi cant differences in F eno between old and young patients with asthma correlated with F eno in only the young patients with asthma. This suggests that the between-group difference in the contribution of airway infl ammation to AHR was not due to differences in treatment. Alternatively, low F eno and the lack of association between F eno and AHR in old patients with asthma may be a result of different infl ammatory profi les in old and young patients with asthma. Sputum neutrophils are known to increase with age; however, there is little change in eosinophils. 11 Sputum was not collected in the present study, so we were unable to determine the infl ammatory subtypes of the subjects. However, previous studies have shown that F eno correlates well with sputum eosinophils. 8 Thus, the absence of any association between AHR and F eno in the old patients with asthma suggests that eosinophilic airway infl ammation is not an important determinant of AHR in this group. Cluster analysis studies have shown that airway infl ammation, airway obstruction, and AHR belong to different clusters in asthma models. 26 The observation that infl ammation (F eno ) is a strong predictor of AHR in young, but not in old, patients with asthma could suggest that the dominant clusters that determine asthma phenotype differ in old and young patients with asthma. Disease duration may also play a role in the pathophysiology of AHR. In a previous study of relatively young adults, infl ammation was associated with AHR in subjects with short ( Յ 16 years) but not with long ( . 16 years) duration of asthma. 27 In older patients with asthma, chronic infl ammation associated with longstanding disease increases remodeling in the airways. 28 In the current study, duration of disease was much longer in the old group than in the young group, as expected, but there was no association between AHR and disease duration in either group. This suggests that, in these subjects, there are no additional, independent effects of disease duration on AHR after accounting for age. The crosssectional design of the study allowed us to determine if the predictors of AHR differed between old and young patients with asthma, but it did not allow us to distinguish between the effects of aging and longstanding disease. important features of asthma at all ages. Our fi ndings are consistent with this view, and we found that AHR is a signifi cant predictor of asthma control in both young and old patients with asthma. However, the differences in the pathophysiology suggest that AHR in old patients with asthma is related to disease processes that occur in small, peripheral airways.
The patients included in this study had asthma diagnosed by a physician and were currently taking treatment of asthma consistent with the defi nition used in recent large clinical trials. 24 Subjects were not required to have AHR, because AHR to methacholine is not specifi c for asthma and because responsiveness can be reduced into the nonresponsive range by treatment with ICS. 25 The inclusion of subjects without AHR meant that the sample included a wide spectrum of subjects with asthma from mild, welltreated subjects to untreated or severe disease. It is unlikely that the old group included a signifi cant proportion with COPD because smoking history in both groups was negligible. One of the strengths of this study was the use of the DRS, which is a continuous measure of the severity of airway responsiveness. This allowed the predictors of airway responsiveness to be determined across the whole range of responses in the sample, without relying on the arbitrary defi nition of AHR. It is noteworthy that when the analysis was limited to those subjects with AHR, the predictors of the severity of AHR in the old group were unchanged. However in the young group, F eno was no longer a predictor of AHR, suggesting that high F eno predicts the presence, but not the severity, of AHR.
The results of the current study show that the relationship between AHR and airway infl ammation differs in old and young patients with asthma. Airway infl ammation, measured directly by sputum infl ammatory cells or indirectly by F eno , is a wellestablished predictor of AHR, 8, 9 which is consistent with our fi ndings in young patients with asthma. In the current study, F eno in old patients with asthma was within normal limits, 18 which may be due to the large proportion of the group on ICS treatment. In the subset of subjects taking regular inhaled ICSs, F eno was similar in old and young; however, DRS the closure-related increase in RV is accompanied by an increase in total lung capacity. Old subjects with peripheral airway abnormalities that predispose the subject to airway closure may be at particular risk if they also have elevated baseline RV or total lung capacity, since any additional airway closure during challenge would bring them closer to the limit of chest wall expansion. Airway closure is a clinically important feature of asthma, since it is a signifi cant predictor of the severity of AHR 10 and is a risk factor for severe asthma exacerbations. 14 In this study we found that the pathophysiologic processes that determine AHR in old patients with asthma differ from those in the young. Specifi cally, our results show that AHR in old patients with asthma is determined by abnormalities in peripheral airways. The clinical implications of this fi nding are that gastrapped and diffusion-dependent areas of the lung in old patients with asthma may not respond well to conventional inhaled medications. These fi ndings suggest that, to reduce morbidity and mortality in old patients with asthma, different systemic treatments may be required to effectively target peripheral airways where airway closure and gas trapping occur. Further studies will be needed to better understand the mechanisms that underlie AHR in the elderly and determine the separate effects of disease and aging on AHR.
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Spirometric measures of airway obstruction were signifi cant predictors of DRS independent of age, which is consistent with previous studies. 10, 22 The association between baseline airway caliber and AHR is often explained in terms of a geometric effect, whereby bronchoconstriction has a much greater effect on airways with small starting caliber than on those with larger caliber. 29, 30 Baseline airway caliber can be reduced by disease-and agerelated factors, which include loss of lung elastic recoil, airway wall remodeling, infl ammation, and changes in surface active forces. These factors may also increase ventilation heterogeneity. In the present study, airway caliber was adjusted for age by using the percent predicted values in the regression models, and the asso ciation between baseline airway caliber and AHR was independent of ventilation heterogeneity.
In the current study, AHR was predicted by Sacin in old patients with asthma. Because Sacin refl ects ventilation heterogeneity in diffusion-dependent airways, rather than in the convection-dependent airways refl ected by Scond, this fi nding suggests that AHR in old patients with asthma involves very peripheral airways. It is unknown whether the anatomic boundaries of Scond and Sacin change with age or disease. In the present study, Sacin was greater in the old patients with asthma than in the young; however, it is unclear whether this was due to aging itself or to disease processes. In healthy adults, ventilation heterogeneity increases with age since both the lung clearance index and the phase 3 slope of the single-breath nitrogen washout increase sharply after 50 years of age. 13, 31 However, to our knowledge, there are no published data about the effect of aging on Sacin. In the current study, multivariate analysis in the old group showed that age was not an independent predictor of AHR, suggesting that the relationship between AHR and Sacin in old subjects was due to disease rather than the aging process. The precise mechanisms by which increased ventilation heterogeneity contributes to AHR are unknown; however, computational modeling predicts that in the presence of uniform airway smooth muscle activation, increased ventilation heterogeneity may lead to large-scale but localized regions of airway closure. 32 Baseline airway closure, measured by RV, was a signifi cant predictor of AHR in the old, but not the young, patients with asthma in the present study. Old patients with asthma are at increased risk of airway closure, measured by the change in FVC during bronchial challenge, 33 but it is not known whether subjects who are predisposed to increased airway closure during challenge are more likely to have gas trapping at baseline. Irvin and Bates 34 proposed that airway closure is central to AHR in asthma, and that
